Global Needles Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Delivery Site;

Intradermal, Subcutaneous, Intravenous, ntramuscular, and Intraperitoneal

By Product;

Suture, Blood Collection, and Insufflation

By Application;

Pen Needles in Diabetes, Blood Collection Needles, Surgical Sutures Needles, Ophthalmic Procedure Needles, Dentistry Needle, Insufflation Needle, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn121165853 Published Date: June, 2025 Updated Date: July, 2025

Needles Market Overview

Needles Market (USD Million)

Needles Market was valued at USD 7,130.57 million in the year 2024. The size of this market is expected to increase to USD 10,792.74 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.1%.


Global Needles Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 6.1 %


Study Period2025 - 2031
Base Year2024
CAGR (%)6.1 %
Market Size (2024)USD 7,130.57 Million
Market Size (2031)USD 10,792.74 Million
Market ConcentrationMedium
Report Pages389
7,130.57
2024
10,792.74
2031

Major Players

  • Medtronic (Ireland)
  • Ethicon US, LLC. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Novo Nordisk A/S (Denmark), BD (U.S.)
  • Stryker (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Luminex Corporation ((U.S.)
  • Illumina, Inc (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • QIAGEN (Netherlands)
  • Abcam plc (U.K.)
  • Merck KGaA (Germany)
  • Promega Corporation (U.S.)
  • Siemens (Germany)
  • PerkinElmer, Inc. (U.S.)
  • Shimadzu Corporation (Japan)

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Needles Market

Fragmented - Highly competitive market without dominant players


The Needles Market is witnessing considerable growth driven by increasing demand in medical procedures and diagnostic applications. With over 65% usage rate in therapeutic injections, the market is evolving to accommodate advanced technologies and safety innovations. Rising concerns over cross-contamination and needlestick injuries are prompting the development of safety-engineered needles, boosting adoption across clinical settings. The market also reflects an increasing shift toward single-use sterile needles, enhancing procedural efficiency and hygiene.

Strategic Collaborations and Mergers
Mergers and collaborative partnerships account for over 52% of business development strategies in the Needles Market. Companies are actively investing in joint ventures to strengthen R&D and broaden their technological capabilities. These partnerships often focus on developing eco-friendly materials, enhancing both product lifecycle and sustainability. Mergers are also being used as a route to accelerate market penetration in high-demand sectors such as outpatient care and chronic disease management.

Opportunities and Growth Initiatives
There are rising opportunities in personalized medicine, contributing to a 61% increase in customized needle-based therapies. Initiatives to improve home-based care solutions and minimally invasive procedures are further propelling the market. Additionally, companies are introducing multi-functional needles designed to integrate diagnostics and treatment, offering a compelling opportunity for market expansion. These developments align with the broader trend of improving patient-centric care through precision devices.

Future Outlook and Innovation Trends
The future outlook for the Needles Market remains promising, driven by technological integration and innovation-focused strategies. Approximately 60% of market leaders are prioritizing investments in AI-assisted needle guidance systems and robotic-controlled injections. As demand for accuracy, efficiency, and safety grows, the market is expected to see strong momentum in automation and smart needle systems. Continued focus on product innovation and expansion strategies will play a crucial role in shaping the market's long-term trajectory.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Delivery Site
    2. Market Snapshot, By Product
    3. Market Snapshot, By Application
    4. Market Snapshot, By Region
  4. Needles Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising chronic disease prevalence
        2. Demand for minimally invasive procedures
        3. Growing geriatric population
        4. Patient safety importance
        5. Point-of-care diagnostics adoption
      2. Restraints
        1. Regulatory hurdles
        2. Limited healthcare access
        3. Needlestick injury concerns
        4. Sterilization and waste issues
        5. Skilled professional shortages
      3. Opportunities
        1. Safety needle tech development
        2. Real-time smart needle adoption
        3. Needle-free drug delivery
        4. Tailored needle solutions
        5. Telemedicine needle integration
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Needles Market, By Delivery Site, 2021 - 2031 (USD Million)
      1. Intradermal
      2. Subcutaneous
      3. Intravenous
      4. ntramuscular
      5. Intraperitoneal
    2. Needles Market, By Product 2021 - 2031 (USD Million)
      1. Suture
      2. Blood Collection
      3. Insufflation
    3. Needles Market, By Application, 2021 - 2031 (USD Million)
      1. Pen Needles in Diabetes
      2. Blood Collection Needles
      3. Surgical Sutures Needles
      4. Ophthalmic Procedure Needles
      5. Dentistry Needle
      6. Insufflation Needle
      7. Others
    4. Needles Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Medtronic (Ireland)
      2. Ethicon US, LLC. (U.S.)
      3. Thermo Fisher Scientific Inc. (U.S.)
      4. Novo Nordisk A/S (Denmark), BD (U.S.)
      5. Stryker (U.S.)
      6. Boston Scientific Corporation (U.S.)
      7. Luminex Corporation ((U.S.)
      8. Illumina, Inc (U.S.)
      9. Bio-Rad Laboratories, Inc. (U.S.)
      10. QIAGEN (Netherlands)
      11. Abcam plc (U.K.)
      12. Merck KGaA (Germany)
      13. Promega Corporation (U.S.)
      14. Siemens (Germany)
      15. PerkinElmer, Inc. (U.S.)
      16. Shimadzu Corporation (Japan)
  7. Analyst Views
  8. Future Outlook of the Market